5-alkyl-2-(alkylthio)-6-(2,6-dihalophenylmethyl)-3,4-dihydropyrimidin- 4(3H)-ones: Novel potent and selective dihydro-alkoxy-benzyl-oxopyrimidine derivatives

Journal of Medicinal Chemistry

Volumn 42, Issue 4, 1999, Pages 619-627

  Mai, Antonello ^a   Artico, Marino ^a   Sbardella, Gianluca ^a   Massa, Silvio ^b   Novellino, Ettore ^c   Greco, Giovanni ^d   Loi, Anna Giulia ^e   Tramontano, Enzo ^e   Marongiu, Maria Elena ^e   La Colla, Paolo ^e  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF SIENA   (Italy)

^c UNIVERSITY OF SALERNO   (Italy)

^d UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^e UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

PYRIMIDINE DERIVATIVE; RNA DIRECTED DNA POLYMERASE; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ANTIVIRAL ACTIVITY; ARTICLE; CHEMICAL MODIFICATION; DRUG CYTOTOXICITY; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; MOLECULAR MODEL; STRUCTURE ACTIVITY RELATION; T LYMPHOCYTE;

EID: 0033602141     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm980260f     Document Type: Article

References (41)

1. Artico, M. Nonnucleoside anti-HIV-1 reverse transcriptase inhibitors (NNRTIs): a chemical survey from lead compounds to selected drugs for clinical trials. Farmaco 1996, 51, 305-331.
2. De Clercq, E. Toward Improved Anti-HIV Chemotherapy: Therapeutic Strategies for Intervention with HIV Infections. J. Med. Chem. 1995, 38, 2491-2517.
3. De Clercq, E. Antiviral Therapy for Human Immunodeficiency Virus Infections. Clin. Microbiol. Rev. 1995, 8, 200-239.
4. Vanhove, G. F.; Gries, J.-M.; Verotta, D.; Sheiner, L. B.; Coombs, R.; Collier, A. C.; Blaschke, T. F. Exposure-Response Relationships for Saquinavir, Zidovudine, and Zalcitabine in Combination Therapy. Antimicrob. Agents Chemother. 1997, 41, 2433-2438.
5. De Clercq, E.; Balzarini, J. Knocking out Human Immunodeficiency Virus Through Nonnucleoside Reverse Transcriptase Inhibitors used as single agents or in Combinations: a Paradigm for the cure of AIDS? Farmaco 1995, 50, 735-747.
6. Tanaka, H.; Baba, M.; Hayakawa, H.; Sakamaki, T.; Miyasaka, T.; Ubasawa, M.; Takashima, H.; Sekiya, K.; Nitta, I.; Shigeta, S.; Walker, R. T.; Balzarini, J.; De Clercq, E. A New Class of HIV-1-Specific 6-Substituted Acyclouridine Derivatives: Synthesis and Anti-HIV-1 Activity of 5-or 6-Substituted Analogues of 1-[(2-Hydroxyethoxy)methyl]-6-(phenylthio)thymine (HEPT). J. Med. Chem. 1991, 34, 349-357.
7. Baba, M.; Shigeta, S.; Tanaka, H.; Miyasaka, T.; Ubasawa, M.; Umezu, K.; Walker, R. T.; Pauwels, R.; De Clercq, E. Highly Potent and Selective Inhibition of HIV-1 Replication by 6-Phenylthiouracil Derivatives. Antiviral Res. 1992, 17, 245-264.
8. Botta, M.; Artico, M.; Massa, S.; Gambacorta, A.; Marongiu, M. E.; Pani, A.; La Colla, P. Synthesis, Antimicrobial and Antiviral Activities of Isotrimethoprim and some related Derivatives. Eur. J. Med. Chem. 1992, 27, 251-257.
9. Artico, M.; Massa, S.; Mai, A.; Marongiu, M. E.; Piras, G.; Tramontano, E.; La Colla, P. 3,4-Dihydro-2-alkoxy-6-benzyl-4-oxopyrimidines (DABOs): a New Class of Specific Inhibitors of Human Immunodeficiency Virus Type 1. Antiviral Chem. Chemother. 1993, 4, 361-368.
10. Tramontano, E.; Marongiu, M. E.; De Montis, A.; Loi, A. G.; Artico, M.; Massa, S.; Mai, A.; La Colla, P. Characterization of the Anti-HIV-1 Activity of 3,4-Dihydro-2-alkoxy-6-benzyl-4-oxopyrimidines (DABOs), New Non-Nucleoside Reverse Transcriptase Inhibitors. Microbiologica 1994, 17, 269-279.
11. Massa, S.; Mai, A.; Artico, M.; Sbardella, G.; Tramontano, E.; Loi, A. G.; Scano, P.; La Colla, P. Synthesis and antiviral activity of new 3,4-dihydro-2-alkoxy-6-benzyl-4-oxopyrimidines (DABOs), specific inhibitors of human immunodeficiency virus Type-1. Antiviral Chem. Chemother. 1995, 6, 1-8.
12. Mai, A.; Artico, M.; Sbardella, G.; Massa, S.; Loi, A. G.; Tramontano, E.; Scano, P.; La Colla, P. Synthesis and anti-HIV-1 Activity of Thio Analogues of Dihydroalkoxybenzyloxopyrimidines. J. Med. Chem. 1995, 38, 3258-3263.
13. Mai, A.; Artico, M.; Sbardella, G.; Quartarone, S.; Massa, S.; Loi, A. G.; De Montis, A.; Scintu, F.; Putzolu, M.; La Colla, P. Dihydro(alkylthio)(naphthylmethyl)oxopyrimidines: Novel Non-Nucleoside Reverse Trasncriptase Inhibitors of the S-DABO Series. J. Med. Chem. 1997, 40, 1447-1454.
14. Ren, J.; Esnouf, R.; Garman, E.; Somers, D.; Ross, C.; Kirby, I.; Keeling, J.; Darby, G.; Jones, Y.; Stuart, D.; Stammers, D. High-Resolution Structures of HIV-1 RT from four RT-Inhibitor Complexes. Nature Struct. Biol. 1995, 2, 293-302.
15. Aroyan, A. A.; Kramer, M. S. Pyrimidine derivatives. Substituted 6-(4′-alkoxybenzyl)pyrimidines. Arm. Khim. Zh. 1971, 24, 161-166; Chem. Abstr. 1971, 75, 49022w.
16. Aroyan, A. A.; Kramer, M. S. Pyrimidine derivatives. Substituted 6-(4′-alkoxybenzyl)pyrimidines. Arm. Khim. Zh. 1971, 24, 161-166; Chem. Abstr. 1971, 75, 49022w.
17. Riegel, B.; Lilienfeld, W. M. The Synthesis of β-Keto Esters by the Decomposition of Acylated Malonic Esters. J. Am. Chem. Soc. 1945, 67, 1273-1275.
18. Monostory, J. New derivatives on carbon atom 6 of thiouracil with antithyroidal effects. An. Asoc. Quim. Argent. 1952, 40, 99-108.
19. Katagiri, N.; Kato, T.; Nakano, J. Studies on Ketene and Its Derivatives. CIX. Synthesis of Naturally Occurring Anthracene-9,10-diones. Chem. Pharm. Bull. 1982, 30, 2440-2446.
20. Miller, W. H.; Dessert, A. M.; Anderson, G. W. The Synthesis of Some 6-Substituted-2-thiouracils. J. Am. Chem. Soc. 1948, 70, 500-502.
21. Moody, C. J.; Rahimtoola, K. F. Diels-Alder Reactivity of Pyrano[4,3-b]indol-3-ones, Indole 2,3-Quinodimethane Analogues. J. Chem. Soc., Perkin Trans. 1 1990, 673-679.
22. Ohkubo, M.; Kuno, A.; Sakai, H.; Sugiyama, Y.; Takasugi, H. Studies on Cerebral Protective Agents. VI. Synthesis of Novel 4-(4-Nitrobenzoyl)pyrimidine and Related Compounds with Anti-anoxic Activity. Chem. Pharm. Bull. 1994, 42, 1279-1285.
23. Capozzi, G.; Roelens, S.; Talami, S. A Protocol for the Efficient Synthesis of Enantiopure β-Substituted β-Lactones. J. Org. Chem. 1993, 58, 7932-7936.
24. Danel, K.; Nielsen, C.; Pedersen, E. B. Anti-HIV Active Naphthyl Analogues of HEPT and DABO. Acta Chem. Scand. 1997, 51, 426-430.
25. Moinet, G.; Dostert, P.; Bourgery, G. Heterocyclic aminoalkoyl derivatives and their therapeutic use. Belg. BE 891,526, June 18, 1982, FR Appl. 80/27,252, Dec 22, 1980; Chem. Abstr. 1982, 97, 216027q.
26. Fenner, H.; Teichmann, R. Pyrimido[5,4-b]chinoline-10-Deaza-alloxazine. Arch. Pharm. (Weinheim) 1978, 311, 115-125.
27. Clark, M.; Cramer, R. D., III; Van Opdenbosch, N. Validation of the General Purpose Tripos 5.2 Force Field. J. Comput. Chem. 1989, 10, 982-1012.
28. SYBYL Molecular Modeling System (version 6.2), TRIPOS Assoc., St. Louis, MO.
29. Protein Data Bank entry codes 1RTI, 1VRT, 1RTH, 1HNI, 1VRU, 1HNV, 1REV, 1RT1, 1RT2.
30. Bernstein, F. C.; Koetzle, T. F.; Williams, G. J. B.; Meyer, E. F., Jr.; Brice, M. D.; Rodgers, J. R.; Kennard, O.; Shimanouchi, T.; Tasumi, T. The Protein Data Bank: A Computer Based Archival File for Macromolecular Structures. J. Mol. Biol. 1977, 112, 535-542.
31. Schäfer, W.; Friebe, W.-G. F.; Leinert, H.; Mertens, A.; Poll, T.; von der Saal, W.; Zilch, H.; Nuber, B.; Ziegler, M. L. Nonnucleosides Inhibitors of HIV-1 Reverse Transcriptase: Molecular Modeling and X-ray Structure Investigations. J. Med. Chem. 1993, 36, 726-732.
32. Hopkins, A. L.; Ren, J.; Esnouf, R M.; Willcox, B. E.; Jones, E. Y.; Ross, C.; Miyasaka, T.; Walker, R. T.; Tanaka, H.; Stammers, D. K.; Stuart, D. I. Complexes of HIV-1 Reverse Transcriptase with Inhibitors of the HEPT Series Reveal Conformational Changes Relevant to the Design of Potent Non-Nucleoside Inhibitors. J. Med. Chem. 1996, 39, 1589-1600.
33. Baba, M.; Shigeta, S.; Yuasa, S.; Takashima, H.; Sekiya, K.; Ubasawa, M.; Tanaka, H.; Miyasaka, T.; Walker, R. T.; De Clercq, E. Preclinical Evaluation of MKC-442, a Highly Potent and Specific Inhibitor of Human Immunodeficiency Virus Type 1 in Vitro. Antimicrob. Agents Chemother. 1994, 38, 688-692.
34. Merluzzi, V. J.; Hargrave, K. D.; Labadia, M.; Grozinger, K.; Skoog, M.; Wu, J. C.; Shih, C.-K.; Eckner, K.; Hattox, S.; Adams, J.; Rosenthal, A. S.; Faanes, R.; Eckner, R. J.; Koup, R. A.; Sullivan, J. L. Inhibition of HIV-1 Replication by a Nonnucleoside Reverse Transcriptase Inhibitor. Science 1990, 250, 1411-1413.
35. Hargrave, K. D.; Proudfoot, J. R.; Grozinger, K. G.; Cullen, E.; Kapadia, S. R.; Patel, U. R.; Fuchs, V. U.; Mauldin, S. C.; Vitous, J.; Behnke, M. L.; Kluinder, J. M.; Pal, K.; Skiles, J. V.; McNeil, D. W.; Rose, J. M.; Chow, G. C.; Skoog, M. T.; Wu, J. C.; Schmidt, G.; Engel, W. W.; Eberlein, W. G.; Saboe, T. D.; Campbell, S. J.; Rosenthal, A. S.; Adams, J. Novel Nonnucleoside Inhibitors of HIV-1 Reverse Transcriptase. 1. Tricyclic Pyridobenzo-and Dipyridodiazepinones. J. Med. Chem. 1994, 34, 2231-2241.
36. Ettorre, A.; Mai, A.; Artico, M.; Massa, S.; De Montis, A.; La Colla, P. 6-(3-Methylbenzyl)-2-(2-methylpropyl)thio-4(3H)-pyrimidinone (DABO 622). Acta Crystallogr. 1996, C52, 2115-2117.
37. Gasteiger, J.; Marsili, M. Iterative Partial Equalization of Orbital Electronegativity. Tetrahedron 1980, 36, 3219-3228.
38. Purcel, V. P.; Singer, J. A. A Brief Review and Table of Semiepirical Parameters Used in the Hückel Molecular Orbital Methodology. J. Chem. Eng. Data 1967, 12, 235-246.
39. Head, J.; Zerner, M. C. A Broyden-Fletcher-Goldfarb-Shanno Optimization Procedure for Molecular Geometries. Chem. Phys. Lett. 1985, 122, 264-274.
40. Pauwels, R.; Balzarini, J.; Baba, M.; Snoeck, R.; Schols, D.; Herdewijn, P.; Desmyster, J.; De Clercq, E. Rapid and Automated Tetrazolium-Based Assay for the Detection of anti-HIV Compounds. J. Virol. Methods 1988, 20, 309-321.
41. Tramontano, E.; Cheng, Y.-C. HIV-1 Reverse Transcriptase Inhibition by a Dipyridodiazepinone Derivative: BI-RG-587. Biochem. Pharmacol. 1992, 43, 1371-1376.